Authors’ Reply to Noguchi et al. Comment on: “Differences in the Adverse Event Profiles of Sodium-Glucose Cotransporter 2 Inhibitors Used in Patients with Diabetes and Heart Failure: An Analysis Using the Japanese Adverse Drug Event Report Database”
- 24 December 2024
- journal article
- research article
- Published by Springer Nature in Clinical Drug Investigation
- Vol. 45 (1) , 47-49
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Differences in the Adverse Event Profiles of Sodium-Glucose Cotransporter 2 Inhibitors used in Patients with Diabetes Mellitus and Heart Failure: An Analysis Using the Japanese Adverse Drug Event Report DatabaseClinical Drug Investigation, 2024
- SGLT-2 inhibitors and euglycemic diabetic ketoacidosis/diabetic ketoacidosis in FAERS: a pharmacovigilance assessmentActa Diabetologica, 2022
- Acute Renal Failure, Ketoacidosis, and Urogenital Tract Infections with SGLT2 Inhibitors: Signal Detection Using a Japanese Spontaneous Reporting DatabaseClinical Drug Investigation, 2020
- Subtype‐Dependent Reporting of Stroke With SGLT2 Inhibitors: Implications From a Japanese Pharmacovigilance StudyThe Journal of Clinical Pharmacology, 2019
- Sodium–glucose cotransporter 2 inhibitor‐associated diabetic ketoacidosis in patients with type 1 diabetes: Metabolic imbalance as an underlying mechanismJournal of Diabetes Investigation, 2019
- Sodium glucose cotransporter 2 inhibitors and risk of serious adverse events: nationwide register based cohort studyBMJ, 2018
- Ketoacidosis associated with SGLT2 inhibitor treatment: Analysis of FAERS dataDiabetes/Metabolism Research and Reviews, 2017
- Ketosis and diabetic ketoacidosis in response to SGLT2 inhibitors: Basic mechanisms and therapeutic perspectivesDiabetes/Metabolism Research and Reviews, 2017
- SGLT2 Inhibitors: A Systematic Review of Diabetic Ketoacidosis and Related Risk Factors in the Primary LiteraturePharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2017
- Euglycemic diabetic ketoacidosis induced by SGLT2 inhibitors: possible mechanism and contributing factorsJournal of Diabetes Investigation, 2015